About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Pdx1tm1Ted
targeted mutation 1, Thomas Edlund
MGI:2152755
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Pdx1tm1Ted/Pdx1tm1Ted involves: 129P2/OlaHsd MGI:2173182
ht2
Pdx1tm1Ted/Pdx1+ involves: 129P2/OlaHsd MGI:3531547
cn3
Insrtm1Khn/Insrtm1Khn
Pdx1tm1Ted/Pdx1+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129S4/SvJae * C57BL/6 * DBA/2 MGI:3583116


Genotype
MGI:2173182
hm1
Allelic
Composition
Pdx1tm1Ted/Pdx1tm1Ted
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdx1tm1Ted mutation (0 available); any Pdx1 mutation (28 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• all homozygotes die within a few days after birth

digestive/alimentary system
• mutant intestines are of normal length and show no overt abnormalities; however, the loops of the small intestine are positioned slightly differently in the abdomen relative to wild-type

endocrine/exocrine glands
• at E10, the mutant dorsal pancreatic epithelium forms a bud but then becomes growth arrested and fails to lobulate
• at E11 and E12, the dorsal bud is significantly smaller than wild-type; the remaining, growth-arrested bud remains unbranched
• at E10-E12, the mutant ventral pancreatic bud appears to be absent
• although the mutant pancreatic epithelium is growth-arrested, the dorsal pancreatic mesenchyme grows and develops normally, with a morphologically normal, bud-like shape found at its normal position
• notably, the mutant mesenchyme is functionally active and able to promote morphogenesis and differentiation of pancreatic epithelium when recombined in vitro; in contrast, mutant pancreatic epithelium cannot be rescued by adding wild-type mesenchyme
• at E13.5, the mutant dorsal pancreatic mesenchyme is present as a "hollow pocket" that can be dissected away from the stomach and duodenum; in wild-type E13-E14 embryos, this mesenchymal pocket is filled by pancreatic epithelium
• at E10, early glucagon cells are present but are unable to proliferate and/or differentiate; a few early insulin cells are present at E10, but are no longer detectable at E13, in the absence of increased apoptosis
• homozygotes completely lack a pancreas; no pancreatic tissue is present in E15.5 embryos or neonates
• notably, the duodenum (from which the pancreas develops) has a normal C-shaped form; no ectopic expression of insulin and pancreatic amylase is detected in the developing duodenum
• the pancreatic duct is missing; however, the common bile duct is present, indicating that apart from the lack of pancreas, the duodenal tract is normally developed

growth/size/body
• homozygotes appear morphologically normal but are slightly smaller than wild-type and heterozygous littermates: on average, ~80% for newborn pups and ~60% for 2-day-old pups

homeostasis/metabolism
• pups that are able to feed and live for more than 2 days exhibit elevated glucose levels, suggesting that the cause of death is partly due to insulin deficiency

immune system
N
• mutant spleens are of normal weight and show no apparent abnormalities relative to wild-type

liver/biliary system
N
• mutant livers are of normal weight and show no apparent abnormalities relative to wild-type




Genotype
MGI:3531547
ht2
Allelic
Composition
Pdx1tm1Ted/Pdx1+
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdx1tm1Ted mutation (0 available); any Pdx1 mutation (28 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• isolated heterozygous islets are significantly more susceptible to apoptosis at basal glucose concentrations than wild-type islets
• however, no significant differences are noted at high glucose (25 mM) or Ca2+ stress
• dispersed beta cells are significantly more susceptible to apoptosis at basal glucose concentrations than wild-type islets
• however, no significant differences are noted at high glucose (25 mM) or Ca2+ stress

endocrine/exocrine glands
• isolated heterozygous islets are significantly more susceptible to apoptosis at basal glucose concentrations than wild-type islets
• however, no significant differences are noted at high glucose (25 mM) or Ca2+ stress
• dispersed beta cells are significantly more susceptible to apoptosis at basal glucose concentrations than wild-type islets
• however, no significant differences are noted at high glucose (25 mM) or Ca2+ stress
• islet isolation procedures generate very few islets (always <100) from heterozygotes compared with wild-type mice (almost always >200 islets)
• isolated heterozygous islets appear fragmented and slightly smaller than wild-type
• in vivo, heterozygotes show a striking disruption of islet architecture and expansion of islet microvasculature at 3 months; however, even at 12 months, some heterozygous islets show no signs of damage or apoptosis
• in heterozygotes, islet number fails to increase with age and is ~50% less than wild-type by 12 months
• in heterozygotes, beta cell mass fails to increase with age and is ~50% less than wild-type by 12 months
• reduced beta cell mass is mirrored by a lower pancreatic insulin content in older mice and can be explained by a reduced number of functional islets, rather than a reduction in insulin stored in single beta cells
• perfused pancreata from heterozygous males display attenuated first-phase insulin secretion in response to a stepwise increase in glucose concentration from 5 mM to 20 mM glucose
• mutant pancreata show a reduced insulin release in response to 20 mM KCl; in the continued presence of 26 mM glucose, the large response to 20 mM arginine is also reduced
• insulin secretion in perfusion or static incubation experiments in response to glucose and other secretagogues is similar in islets isolated from heterozygous mutants compared with wild-type littermates
• glucose sensing and islet Ca2+ responses are normal in large, intact heterozygous mutant islets
• at 12 months, older heterozygotes exhibit infiltration of lymphocytes (some TUNEL-positive) within or around islets
• immunofluorescent localization of Ki67 nuclear antigen indicates proliferation of lymphocytes within these islets

homeostasis/metabolism
• perfused pancreata from heterozygous males display attenuated first-phase insulin secretion in response to a stepwise increase in glucose concentration from 5 mM to 20 mM glucose
• mutant pancreata show a reduced insulin release in response to 20 mM KCl; in the continued presence of 26 mM glucose, the large response to 20 mM arginine is also reduced
• insulin secretion in perfusion or static incubation experiments in response to glucose and other secretagogues is similar in islets isolated from heterozygous mutants compared with wild-type littermates
• glucose sensing and islet Ca2+ responses are normal in large, intact heterozygous mutant islets
• heterozygous mutant males exhibit significantly elevated blood glucose concentrations relative to wild-type males
• notably, heterozygous females display an attenuated increase in blood glucose levels relative to wild-type
• heterozygotes exhibit a decline in glucose tolerance with increasing age (J:82969)

immune system
• at 12 months, older heterozygotes exhibit infiltration of lymphocytes (some TUNEL-positive) within or around islets
• immunofluorescent localization of Ki67 nuclear antigen indicates proliferation of lymphocytes within these islets




Genotype
MGI:3583116
cn3
Allelic
Composition
Insrtm1Khn/Insrtm1Khn
Pdx1tm1Ted/Pdx1+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Insrtm1Khn mutation (1 available); any Insr mutation (69 available)
Pdx1tm1Ted mutation (0 available); any Pdx1 mutation (28 available)
Speer6-ps1Tg(Alb-cre)21Mgn mutation (6 available); any Speer6-ps1 mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• these mutants fail to exhibit an adaptive islet hyperplastic response to insulin resistance; instead, pancreatic beta cell mass is reduced, and islets appear small with scattered non-beta cells





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Copyright, and Privacy Statement
Send questions and comments to User Support.
last database update
01/24/2023
MGI 6.22
The Jackson Laboratory